Additional file 3: of A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination settingâhigh coverage and safety, but no significant impact on transmission
- Ulrika Morris (453636)
- Mwinyi Msellem (3640375)
- Humphrey Mkali (6064058)
- Atiqul Islam (3662896)
- Berit Aydin-Schmidt (453635)
- Irina Jovel (2656228)
- Shija Shija (6064061)
- Mwinyi Khamis (6064064)
- Safia Ali (6064067)
- Lamija Hodzic (6064070)
- Ellinor Magnusson (6064073)
- Eugenie Poirot (829687)
- Adam Bennett (142993)
- Michael Sachs (3113184)
- Joel Tarning (387123)
- Andreas MĂĽrtensson (3507341)
- Abdullah Ali (264521)
- Anders BjĂśrkman (3507344)
Publication date
December 2018
DOIAbstract
Table S1. Adverse events reported during post-MDA surveys (active detection) and at health facilities (passive detection) after mass treatment with DP and SLD primaquine. Table S2a. Risk factors associated with asymptomatic malaria infection at the baseline of the study. Table S2b. Risk factors associated with asymptomatic malaria infection during the follow-up survey three months after completed MDA. (XLSX 30 kb
Add to ORKG